Cargando…

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer

BACKGROUND: Individual immune-related alternative splicing (AS) events have been found to be significant in immune regulation and cancer prognosis. However, a comprehensive analysis of AS events in cancer cells based on immune-related genes (IRGs) has not been performed, and its clinical value is un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yunze, Xu, Lei, Hao, Chuanchuan, Wu, Jin, Jia, Xianhong, Ding, Xia, Lin, Changwei, Zhu, Hongmei, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178000/ https://www.ncbi.nlm.nih.gov/pubmed/35692800 http://dx.doi.org/10.3389/fonc.2022.866289

Ejemplares similares

Noncoding RNAs regulate alternative splicing in Cancer
por: Liu, Yunze, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma
por: Lin, Zijing, et al.
Publicado: (2021)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer
por: Liang, Yichao, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Identification of an alternative splicing signature as an independent factor in colon cancer
por: Chen, Haitao, et al.
Publicado: (2020)

Development of a Prognostic Alternative Splicing Signature Associated With Tumor Microenvironment Immune Profiles in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
por: Yu, Min, et al.
Publicado: (2019)

Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Thyroid Carcinoma
por: Han, Baoai, et al.
Publicado: (2021)

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes
por: Liu, Huan, et al.
Publicado: (2021)

Novel, alternative splicing signature to detect lymph node metastasis in prostate adenocarcinoma with machine learning
por: Xie, Ping, et al.
Publicado: (2023)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Systematic Profiling of Alternative mRNA Splicing Signature for Predicting Glioblastoma Prognosis
por: Chen, Xueran, et al.
Publicado: (2019)

Identification of the Prognostic Signatures of Glioma With Different PTEN Status
por: Zhang, Pei, et al.
Publicado: (2021)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Identification of the prognostic signature based on genomic instability-related alternative splicing in colorectal cancer and its regulatory network
por: Ding, Qiuying, et al.
Publicado: (2022)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer
por: Wu, Jian, et al.
Publicado: (2021)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma
por: Wang, Shuqin, et al.
Publicado: (2022)

Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction
por: Xu, Jie, et al.
Publicado: (2022)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jpu79q649i2ifpo5j4vb6picfl